# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-25-000026
Filing Date
2025-02-06
Accepted
2025-02-06 06:45:11
Documents
61
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | imvt-20241231.htm iXBRL | 10-Q | 1322693
2 | EX-10.1 | exhibit101-20241231q3.htm | EX-10.1 | 71081
3 | EX-31.1 | exhibit311-20241231q3.htm | EX-31.1 | 9759
4 | EX-31.2 | exhibit312-20241231q3.htm | EX-31.2 | 9756
5 | EX-32.1 | exhibit321-20241231q3.htm | EX-32.1 | 4465
6 | EX-32.2 | exhibit322-20241231q3.htm | EX-32.2 | 4486
12 | GRAPHIC | imvt-20241231_g1.jpg | GRAPHIC | 146609
13 | GRAPHIC | imvt-20241231_g2.jpg | GRAPHIC | 155502
| Complete submission text file | 0001764013-25-000026.txt |  | 5950553

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | imvt-20241231.xsd | EX-101.SCH | 28422
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | imvt-20241231_cal.xml | EX-101.CAL | 39742
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | imvt-20241231_def.xml | EX-101.DEF | 203199
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | imvt-20241231_lab.xml | EX-101.LAB | 475188
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | imvt-20241231_pre.xml | EX-101.PRE | 341905
64 | EXTRACTED XBRL INSTANCE DOCUMENT | imvt-20241231_htm.xml | XML | 403942

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 25595376
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)